1 / 14

Concept to Commercialisation A strategy for business innovation, 2011-2015 Zahid Latif Head of Healthcare

Concept to Commercialisation A strategy for business innovation, 2011-2015 Zahid Latif Head of Healthcare. Mark Glover 12 th January 2011. Medicines and Healthcare activities. Assisted Living Innovation Platform. Detection and Identification of Infectious Agents Innovation Platform.

arav
Télécharger la présentation

Concept to Commercialisation A strategy for business innovation, 2011-2015 Zahid Latif Head of Healthcare

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Concept to Commercialisation A strategy for business innovation, 2011-2015 Zahid Latif Head of Healthcare Mark Glover 12th January 2011

  2. Medicines and Healthcare activities Assisted Living Innovation Platform Detection and Identification of Infectious Agents Innovation Platform Stratified Medicine Innovation Platform Regenerative Medicine Biomedical Catalyst

  3. Delivery mechanisms - Competitions • Consortium Investment • “normal” 2-stage • “fast track” 1-stage • feasibility first stage • 2-stage with consortium building workshop/Grand Challenge • sandpit first stage • Single Company Investment • Knowledge Transfer Partnership • Grant for Research and Development • Feasibility studies leading to Collaboration Nation • LaunchPad • SBRI

  4. Delivery mechanisms - Activities • Knowledge Transfer Networks • Networks within communities with similar skills or goals, where knowledge about needs and capabilities can be exchanged • Missions • Opportunities for fast-growing technology companies in the UK to explore opportunities for growth with key investors, potential partners and customers, media and other overseas stakeholders • Centres • Provide a single point of access to world leading research capability • a critical mass of knowledge and skilled personnel • access to expensive or fast evolving capital equipment

  5. Assisted Living: How everything fits together... delivering assisted living l ifestyles a t scale {next stage of evidence with even more users} Assisted Living Innovation Platform (ALIP) {technology development} Preventative Technology Grant (PTG) Whole System Demonstrator (WSD) {clinical evidence} 3ml 2006 2007 2008 2009 2010 2011 2012

  6. dallas overview • 4 communities reaching 169,000 people • the tipping point for going to scale • not an end in themselves... a legacy must be left! • Wellbeing, and top quality health and care • including a preventative approach • integrate products, services and systems to: • enable people to live independently for longer • improve quality of life • create a vibrant and diverse commercial landscape • Investing £37.3m over 3 years (£19.6m from us)

  7. Stratified Medicines is about delivering the right treatment, to the right patient, at the right dose, at the right time. Stratified Medicine Innovation Platform “accelerating stratified medicines in the UK”

  8. A partnership of 7 public and charity sector organisations • Technology Strategy Board • DH England & Wales • Scottish Government Health Directorate • MRC • CRUK • ARUK • NICE

  9. The Detection and Identification ofInfectious Agents Innovation Platform • Aims to: • create business opportunity and wealth in the UK • encourage the development and adoption of commercially viable diagnostic devices • reduce the mortality, morbidity and economic burden due to infectious agents in humans and animals • Focused on point-of-care diagnostics • Supports Department of Health and Defra priorities

  10. Regenerative medicine programme • replaces or regenerates human cells, tissues or organs to restore or establish normal function. • partnership with MRC, BBSRC and EPSRC • Programme of activities to be funded in: • Product development and validation • Tools and Technologies challenge • Value systems and Business models

  11. Aims of the programme: • Underpin and enable the best regenerative medicine businesses to flourish in the UK • • Build a connected regenerative medicine community through the formation of well-linked programmes of work and activities to develop medicines and technology platforms

  12. Joint Technology Strategy Board and Medical Research Council programme investing £180m over 3 years • Deliver growth to the UK life sciences sector through supporting and driving the development of innovative life sciences products and services • Supporting both academically- and commercially-led research and development and encouraging partnership between clinicians, academics and industry • Moving innovative life sciences products and services quicker and more effectively to commercialisation – and ultimately healthcare impact

  13. Catapult Centres • Business-focused centres that make world-leading technical capability available to businesses to solve their technical challenges • Provides - • Access to world-leading technology & expertise • Reach into the knowledge base for world-leading science • Capability to undertake collaborative R&D projects and contract research with business • Strongly business focused with a professional delivery ethos • Critical mass of activity creating a focal point • Skills development at all levels

  14. www.innovateuk.orge: zahid.latif@tsb.gov.ukm: +44 7824 599692tw: zahid_latif_tsb

More Related